12.69 USD
↗ 0.33 (2.67%)LIVE (AS OF 02:19 PM EDT)
Oric Pharmaceuticals, Inc. Common Stock
ORICNASDAQ • USD
Market: OPEN
Shares of Oric Pharmaceuticals, Inc. Common Stock (ORIC) are trading at $12.69. The technical outlook is "Sell" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place ORIC at a fair price relative to peers.
Technical & fundamental data as of Sep 15, 2026.
Open?$12.38
High?$12.77
Low?$12.29
Prev. Close?$12.36
Volume?681.0K
Avg. Volume?1.3M
VWAP?$12.63
Rel. Volume?0.52x
Bid / Ask
Bid?$12.68 × 100
Ask?$12.70 × 100
Spread?$0.02
Midpoint?$12.69
Valuation & Ratios
Market Cap?1.3B
Shares Out?103.7M
Float?64.1M
Float %?62.0%
P/E Ratio?N/A
P/B Ratio?3.36
EPS?-$1.35
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Employees
111
Market Cap
1.3B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-04-24
Address
240 E. GRAND AVE.
SOUTH SAN FRANCISCO, CA 94080
Phone: (650) 388-5600
SOUTH SAN FRANCISCO, CA 94080
Phone: (650) 388-5600
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?35
Piotroski F-Score?0/9Weak
Altman Z-Score?29.62Safe
Confidence?48%Low
Short InterestSqueeze Risk
Short % of Float?26.92%Squeeze Risk
Short Interest?17.3M
Days to Cover?16.2
Free Float64.1M
Avg Daily Volume1.1M
Settlement Date2026-08-31
Financial Health
Current Ratio?13.19Strong
Quick Ratio?13.19Strong
Cash Ratio?1.81Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?3.36FAIR▾
Peers100
S&P50
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-8.0CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-36.8%WEAK▾
S&P3
ROA?-34.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-112258000
Enterprise Value?$1.2B
Fundamentals ratios updated end of day